NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
January 6, 2026 — Tonix Pharmaceuticals announces presentations at Sachs Associates and Biotech Showcase 2026. Learn about its FDA-approved fibromyalgia drug TONMYA and pipeline in CNS, immunology, and infectious diseases.
January 6, 2026 — GeoVax Labs to present 2025 achievements and 2026 strategy at Biotech Showcase and J.P. Morgan Healthcare Conference, highlighting COVID-19, cancer, and Mpox vaccine programs.
January 6, 2026 — Lifespring Chiropractic adds Dr. Sean Ly to its team as demand surges for their nervous-system-focused, non-cracking care model in Austin. Award-winning practice reports lasting patient improvements.
January 6, 2026 — MSAN adds Psych Hub Mental Health Ally Certification to its Leadership Institute for Military Spouses, sponsored by USAA. Training addresses critical mental health gaps.
January 6, 2026 — Illinois' Collaborative Bridges publishes report on protecting behavioral health from federal cuts, showcasing a successful model that reduces readmissions and saves Medicaid funds.
January 6, 2026 — Ourian Plastic Surgery in Beverly Hills launches new breast surgery content covering augmentation, reduction, lifts & reconstruction. Dr. Ariel Ourian offers confidential consultations for LA patients.
January 6, 2026 — Silicon Valley Hair Institute launches new blog content on hair loss solutions, including AI robotic surgery and transgender hair transplantation. Dr. Miguel Canales provides expert insights for Bay Area residents.
January 5, 2026 — HeartBeam announces FDA-cleared cable-free 12-lead ECG technology for arrhythmia assessment, with CEO presenting at JP Morgan 2026 Healthcare Conference ahead of Q1 commercial launch.
January 5, 2026 — Regentis Biomaterials gains U.S. patent for GelrinC, a liquid hydrogel for knee cartilage repair, enhancing surgical ease and patient outcomes in regenerative medicine.
January 5, 2026 — Telomir Pharmaceuticals reports positive Telomir-1 results in triple-negative breast cancer models, showing reduced tumor growth and metastasis with potential synergy with paclitaxel.
January 5, 2026 — WHO reveals 2025 global health progress tempered by climate shocks and funding cuts. Soligenix Inc. develops therapeutics amid challenges. BioMedWire reports on biotechnology sector developments.
January 5, 2026 — HeartBeam announces FDA-cleared cable-free 12-lead ECG tech for arrhythmia assessment, with CEO presenting at JP Morgan 2026 Healthcare Conference ahead of Q1 2026 U.S. launch.
January 5, 2026 — Alcanza Clinical Research acquires Tampa Bay Medical Research, expanding clinical trial access. Dr. Sureka Bollepalli joins Alcanza's network of 25+ research facilities nationwide.
January 5, 2026 — SaveRxCanada.to now offers Ozempic from India at prices starting around $280, saving U.S. patients over $700 per pen compared to retail pharmacies. Learn about affordable prescription options.
January 4, 2026 — Rice Orthodontics in Paducah, KY offers personalized Invisalign treatments with advanced technology, flexible financing, and a patient-focused approach for effective clear aligner care.
January 1, 2026 — Kemal Erkan surpasses 200K YouTube subscribers in 2025, expanding digital healthcare outreach with discussions on bariatric surgery, US economics, and policy impacts.
January 1, 2026 — BioUtah announces new board leadership with Erin Barry as chair and Andrew Hemmert as vice chair, plus three new board members. Changes take effect January 2026 for Utah's life sciences trade association.
December 31, 2025 — Ethema Health Corporation and Addiction Recovery Care LLC mutually terminate partnership LOI. Learn about the impact on addiction treatment services and company growth strategies in Florida and Kentucky.
December 31, 2025 — Nutriband CEO updates shareholders on 2025 achievements & 2026 outlook for AVERSA™ Fentanyl, an abuse-deterrent opioid patch. Includes FDA progress, patents, and financial strategy.
December 31, 2025 — Taiwan researchers discover blocking RUNX2 gene regulator may restore immune responses in cancer patients who stop benefiting from immunotherapy, potentially revolutionizing cancer treatment approaches.